Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM

Transfusion

Volumn 46, Issue 8, 2006, Pages 1323-1327

  Lee, Soohee ^a   Debnath, Asim K ^b   Wu, Xu ^b   Scofield, Terry ^b   George, Terry ^b   Kakaiya, Ram ^b   Yogore III, Mariano G ^b   Sausais, Laima ^b   Yacob, Michelle ^b   Lomas Francis, Christine ^b   Reid, Marion E ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ANTIGEN; DNA; GUANINE NUCLEOTIDE; KALT ANTIGEN; KTIM ANTIGEN; PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD ANALYSIS; BLOOD GROUP KELL SYSTEM; BLOOD SAMPLING; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA ISOLATION; EXON; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HEMAGGLUTINATION TEST; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRON; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; THREE DIMENSIONAL IMAGING;

AMINO ACID SUBSTITUTION; ERYTHROCYTES; EXONS; FEMALE; HUMANS; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; MALE; POINT MUTATION; PREVALENCE;

EID: 33746370373     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00899.x     Document Type: Article

References (18)

1. Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang 1997;73:1-11.
2. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000;37:113-21.
3. Khamlichi S, Bailly P, Blanchard D, et al. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 1995;228:931-4.
4. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem 1998;273:13950-6.
5. Lee S, Zambas ED, Marsh WL, Redman CM. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A 1991;88:6353-7.
6. Ho M, Chelly J, Carter N, et al. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869-80.
7. Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999;94:1440-50.
8. Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001;50:755-64.
9. Lee S, Russo D, Redman C. Functional and structural aspects of the Kell blood group system. Transfus Med 2000;14:93-103.
10. Lee S, Reid ME, Redman CM. Point mutations in KEL Exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system. Vox Sang 2001;81:259-63.
11. Reid ME, Lomas-Francis C. Blood group antigen factsbook. 2nd ed. London: Elsevier/Academic Press; 2004.
12. Judd WJ. Methods in immunohematology. Durham (NC): Montgomery Scientific Publications; 1994.
13. Lee S, Russo DC, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001;276:27281-9.
14. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779-815.
15. Lee S, Debnath AK, Redman CM. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11. Blood 2003;102:3028-34.
16. Oefner C, D'Arcy A, Hennig M, Winkler FK, Dale GE. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J Mol Biol 2000;296:341-9.
17. Laskowski R, MacArthur M, Moss D, Thornton J. PROCHECK: a program to check the sterochemical quality of protein structures. J Appl Cryst 1993;26:283-91.
18. Lee S, Russo DC, Reid ME, Redman CM. Mutations that diminish expression of Kell surface protein and lead to the Kmod RBC phenotype. Transfusion 2003;43:1121-5.